Microbial Services: Your CDMO Partner For Life

Microbial bioproduction demands speed, reliability, and deep process understanding to move complex molecules from early development to commercial manufacturing. A modular, flexible approach enables programs to progress efficiently while managing risk across every stage of the lifecycle. Extensive experience with common microbial hosts—including E. coli, Pichia pastoris, and Saccharomyces cerevisiae — supports development of scalable processes for difficult‑to‑express proteins, potent APIs, and advanced conjugation strategies.

Integrated capabilities span strain selection, process development, and GMP manufacturing, with phase‑appropriate analytical methods designed to support regulatory submissions. Proven expression technologies help accelerate lead strain identification while generating quality data early, reducing downstream uncertainty. Manufacturing scales from early tox material through multi‑kiloliter commercial production, supported by high batch success rates and robust process control strategies.

Modern facilities, advanced automation, and unidirectional material flows enable high‑cadence production and options for dedicated capacity as programs mature. By combining process characterization, validation, and continued process verification, this approach helps teams shorten timelines, strengthen CMC packages, and confidently advance microbial programs toward IND and beyond.

Read the full brochure to see how an end‑to‑end microbial strategy can support your development and commercialization goals.